Screening for high-risk cardiovascular disease: A challenge for the guidelines

Archives of Internal Medicine

Volumn 170, Issue 1, 2010, Pages 40-42

  Smith Jr , Sidney C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; HIGH RISK PATIENT; HUMAN; MEDICAL PRACTICE; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING;

CARDIOVASCULAR DISEASES; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT;

EID: 74549150035     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2009.457     Document Type: Note

References (13)

1. AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003;12(1):18-23.
2. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143-3421.
3. Smith SC Jr, Jackson R, Pearson TA, et al. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation. 2004;109(25):3112- 3121.
4. Yusuf S, Hawken S, Ounpuu S, et al; INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364(9438):937-952.
5. Lanas F, Avezum A, Bautista LE, et al; INTERHEART Investigators in Latin America. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 2007;115(9):1067-1074.
6. Smith SC Jr. Risk factors for myocardial infarction in Latin America: sobrepeso y obesidad. Circulation. 2007;115(9):1061-1063.
7. Peterson ED, Roe MT, Mulgund J, et al. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA. 2006;295(16):1912-1920.
8. Jiang SL, Ji XP, Zhang C, Wang XR, Zhang M, Zhang Y. Impact of Chinese guidelines for management of patients with acute myocardial infarction on outcomes of hospitalized patients. Chin Med J (Engl). 2006;119(1):26-31.
9. Grundy SM. The changing face of cardiovascular risk. J Am Coll Cardiol. 2005;46(1):173-175.
10. Gaziano TA, Steyn K, Cohen DJ, Weinstein MC, Opie LH. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level. Circulation. 2005;112(23):3569-3576.
11. Institute of Medicine. Conflict of Interest in Medical Research, Education and Practice. Washington, DC: National Academies Press; 2009.
12. Antman EM, Gibbons RJ. Clinical practice guidelines and scientific evidence. JAMA. 2009;302(2):143-144, author reply 145-147.
13. Tricoci P, Allen JM, Kramer JM, Califf RM, Smith SC Jr. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009;301(8):831-841.